AREV Partners

What AREV Partners does

AREV Partners is a Paris-headquartered private equity firm founded in 2022 by Xavier Geismar (ex-BCG, ex-Cinven Partner and Head of French office) and Julien Lammoglia (ex-Bain & Company, ex-Cinven, ex-Partners Group Head of PE Directs France). The firm manages the AREV I fund, with committed capital exceeding €300M, and invests initial equity tickets of €25M-75M in European mid-cap companies with enterprise values between €40M and €200M. AREV targets four sectors — Healthcare, Digital & Technology, B2B Services, and Niche Industrials — and pursues a "co-creation" model, typically investing alongside founders and management teams who retain significant ownership (e.g., Marc Wacongne retained 51% of Toutapprendre). The firm has executed five platform investments to date: Toutapprendre (online content for works councils and libraries), Komposite (hybrid cloud and data management), Pinard Group (high-end packaging for beauty and pharma, co-invested with Bluegem), Groupe Ysonut (micronutrition and dietetics laboratory), and NexInLife (MedTech CDMO for catheter manufacturing, acquired from Saint-Gobain Group). Portfolio company revenues disclosed range from roughly €12M (Toutapprendre/Mozaik) to €75M (Pinard Group).

AREV generates revenue through management fees and future carried interest on AREV I; LP identities are not publicly disclosed, and the firm has not yet realized any exits. Deal sourcing is driven by direct professional networks and selective competitive processes (with advisors such as Ever Corporate Finance, Eurvad, and Cambon Partners), supplemented by a corporate website that doubles as a brand and team presence in French and English. The team of eight is organized around multi-European coverage — France headquarters, DACH (Andres Middelschulte, Managing Director), Benelux (David Kusters, Director), and Germany (Juliette Roubi, Investment Manager) — reflecting an explicit pan-European mid-market mandate from inception. The firm is registered as AREV PARTNERS SAS at 11 rue Anatole de la Forge, 75017 Paris, is GDPR-compliant, and operates without a proprietary technology product or disclosed AI capability.

Name

AREV Partners

Legal name

AREV PARTNERS SAS

Website

https://arevpartners.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

AREV Partners is a Paris-based private equity firm managing the €300M+ AREV I fund, investing €25M-75M equity tickets in European mid-cap companies (€40M-200M EV) across Healthcare, Digital & Technology, B2B Services, and Niche Industrials, alongside founders and management teams.

Ownership category

akta.pro rank

Product category

Private Equity Fund Management

NAICS

Funds, Trusts, and Other Financial Vehicles (525)

akta.pro primary industry

Joint Venture CVC / Consortium Funds (Multi-corporate) (FSANAHAE)

Keywords

• Private equity investment
• Growth capital
• Mid-market buyouts
• European private equity
• Minority and majority stakes

Headquarters

HQ city

Forge

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Fund Management: AREV Partners generates revenue through management fees and carried interest from AREV I fund, targeting European unlisted companies with €25M-75M initial investment tickets and €40M-200M enterprise values.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

AREV Partners is a Paris-based private equity firm that manages the AREV I fund (over €300M) and invests €25M-75M initial equity tickets in European unlisted companies with €40M-200M enterprise values. It focuses on four sectors — Healthcare, Digital & Technology, BtoB Services, and Niche Industrials — and invests alongside management teams and founders who typically retain significant ownership.

Product overview

AREV Partners is a private equity firm (not a product/technology company). The 'products' in this extraction represent portfolio companies invested in by AREV I fund, not products or services offered by AREV Partners itself. AREV I invests €25M-75M initial equity tickets in European private companies with enterprise values of €40M-200M, focusing on Healthcare, Digital & Technology, BtoB Services, and Niche Industrials sectors. The portfolio companies include NexInLife (MedTech catheter manufacturing), Ysonut (nutritional supplements), Pinard Group (packaging solutions), Komposite (data management/hybrid cloud), and Mozaik (online content platform).

Differentiator

Problem solved

Functional benefit

Products and services

• AREV I Fund European mid-market private equity fund managed by AREV Partners that invests equity tickets of €25M-75M into unlisted companies valued at €40M-200M, focusing on Healthcare, Digital & Technology, BtoB Services, and Niche Industrials. Investments are executed alongside founders and management teams who retain significant ownership.

Quantifiable outcome

• AREV I completed first investment less than 5 months after fund's first close
• +2 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Eurazeo: Eurazeo is a leading listed European investment firm with sizeable mid-market private equity, growth and private debt activities across healthcare, tech, services and industrials. Highly comparable to AREV on sector focus, ticket size and European mid-market positioning, though at significantly larger AUM scale.
• PAI Partners: PAI Partners is a Paris-headquartered European mid-market private equity firm with significant healthcare, business services and industrials exposure. Comparable on geography and sector emphasis, though operating at a larger fund scale than AREV I.
• Bridgepoint: Bridgepoint is a large European mid-market private equity firm investing across services, healthcare and industrials. Comparable to AREV on sector and European mid-market positioning, with substantially deeper AUM and broader geographic coverage.
• Ardian: Ardian is a Paris-headquartered global private investment house with significant direct PE coverage in European mid-market healthcare, services and industrials. Comparable to AREV on French mid-market origination, though at a much larger scale and broader mandate.

Direct peers

• LBO France: LBO France is a Paris-based mid-market private equity firm investing in French and European companies across healthcare, tech, services and industrials. Directly comparable to AREV in fund size band, sector focus and lower mid-market EV range.
• IK Partners: IK Partners is a European mid-market PE firm with healthcare, business services and industrial sector coverage and pan-European footprint including France, Benelux and DACH. AREV's Managing Director Andres Middelschulte joined from IK Partners, making it a near-direct comparable on focus and geographic remit.
• Astorg: Astorg is a Paris-based European mid-market private equity firm focused on healthcare, business services and technology companies, typically with EV in the €100M-1B range. Direct comparable to AREV on sector mix, ticket size overlap and French/European origination model.
• Montefiore Investment: Montefiore is a Paris-based mid-market private equity firm focused on French services, healthcare and consumer businesses. Comparable to AREV on French mid-market origination, sector overlap (B2B services, healthcare-adjacent) and lower mid-market EV range.
• Keensight Capital: Keensight Capital is a Paris-based growth/buyout firm investing in European technology, healthcare and business services companies. Comparable to AREV on digital & technology and healthcare sector emphasis and on European lower mid-market EV range.
• Alpha Private Equity: Alpha Private Equity is a French mid-market PE firm with Benelux coverage and healthcare/tech/services sector focus. AREV's Director David Kusters joined from Alpha, and the firm's EV range and sector mix closely overlap with AREV I.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/arevpartners

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AREV Partners